The bench was hearing two separate petitions, including the one...
Category:
Health
Latest
Centre renames Ayushman Bharat Health and Wellness Centres as Ayushman Arogya Mandir
The rebranded AB-HWCs will also have a new tagline -- 'Arogyam...
Private general insurers expand market share to 53.58 pc in H1’FY24
According to the Irdai data, up to September 2023 health insurance...
India confirms first death following Covid-19 vaccination
It is the first death linked to Covid-19 vaccination due to anaphylaxis. It re-emphasises the need to wait for 30 minutes at the inoculation centre after receiving the jab.
The panel said benefits of vaccination are overwhelmingly greater than the small risk of harm and as a measure of utmost precaution, emerging signals of harm are being constantly tracked and reviewed periodically.
With child-size needles, France starts giving COVID jab to 12-year-olds
Delta plus variant of COVID-19 is not yet ”variant of concern”: Govt
“This is a variant of interest that has not yet been classified as a variant of concern. A variant of concern is in which we have understood that there are adverse consequences to humanity by increase in transmissibility and severity. This is not known yet about the Delta plus variant,” Paul said.
Indian scientists: We didn’t back doubling of vaccine dosing gap
The ministry of health announced the decision to change the gap from 6-8 weeks to 12-16 weeks on May 13, at a time when supplies of the shot were falling short of demand and infections were surging across the country.
US study: Many facing new medical issues post-Covid
Their most common new health problems were pain, including in nerves and muscles; breathing difficulties; high cholesterol; malaise and fatigue; and high blood pressure. Other issues included intestinal symptoms; migraines; skin problems; heart abnormalities; sleep disorders; and mental health conditions like anxiety and depression. Post-Covid problems were common even among people who had not gotten sick from the virus at all.
No door-to-door vaccine drive in national policy, Centre tells HC
Additional Solicitor General Anil Singh said the Centre, however, kept improvising and updating its policy from time to time and perhaps, sometime in future, it might permit door-to-door vaccination drives.
Singh, said some state governments and municipal bodies had decided to ignore its advisory guidelines and were conducting door-to-door vaccination for special categories of citizens, but it was not possible yet to make such drives a part of the national policy.
How excess sugar consumption causes fatty liver
Non-Alcoholic Fatty Liver Disease (NAFLD) is a condition in which excess fat deposits in the liver. The disease starts silently, with no overt symptoms for as much as two decades. If left untreated, the excess fat can irritate the liver cells, resulting in scarring of the liver (cirrhosis), and in advanced cases, can even lead to liver cancer. The treatment of advanced stages of NAFLD is difficult.
One of the causes for NAFLD is the overconsumption of sugar — both table sugar (sucrose) and other forms of carbohydrates.
Vaccines don’t prevent COVID but will help in keeping symptoms mild: Sangita Reddy
Highlighting the role of vaccines and timely diagnosis and treatment, she said, “The imp point 2 remember- vaccine dont prevent #COVID BUT help keep symptoms Mild. Timely diagnosis & treatment r key 2 quick recovery”.
People must follow appropriate behaviour as Covid-19 has not yet been eradicated, says AIIMS taskforce head Dr Naveet Wig
“Unlock has to take place very slowly. Hotspots have to be taken care of. We must be ready to follow Covid-appropriate behaviour and must personally ensure that us and our families will not get infected. Covid-19 has not gone. There are 10 lakh active Covid-19 patients in the country today,” Dr Wig, who is also the Chairperson of the AIIMS Covid Task Force told ANI.
AstraZeneca shots have good risk-benefit profile for over 60s, says EMA official
The EMA’s position is that the AstraZeneca shot is safe and can be used for all age groups over 18. However several European Union member states have stopped administering it to people below a certain age, usually ranging from 50 to 65, restricting its use to older people, due to very rare cases of blood clotting, mainly among young people.